Benzinga | Mar 4, 2021 10:11AM EST

Canaccord Genuity Initiates Coverage On Histogen with Buy Rating, Announces Price Target of $5

Canaccord Genuity initiates coverage on Histogen (NASDAQ:HSTO) with a Buy rating and announces Price Target of $5.